Answer
Oct 23, 2025 - 11:23 AM
Tagrisso (Osimertinib) is a medication used to treat certain types of non-small cell lung cancer (NSCLC). Specifically, it is prescribed for cancers that have specific mutations in the epidermal growth factor receptor (EGFR) gene, which are often identified through genetic testing. Tagrisso works by inhibiting the activity of EGFR, thereby slowing the growth and spread of cancer cells.
